Evidence on the use of paracetamol in febrile children

Bulletin of the World Health Organization

Volumn 81, Issue 5, 2003, Pages 367-372

  Russell, Fiona M ^a   Shann, Frank ^b   Curtis, Nigel ^a   Mulholland, Kim ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Acetaminophen pharmacology; Bacterial infections drug therapy; Child; Falciparum drug therapy; Febrile seizures drug therapy; Fever drug therapy; Malaria; Meta analysis; Review literature; Treatment outcome; Virus diseases drug therapy

Indexed keywords

ACETYLSALICYLIC ACID; DIAZEPAM; IBUPROFEN; PARACETAMOL;

CHILD HEALTH; DISEASE TREATMENT; DRUG PRESCRIBING; MALARIA;

ARTICLE; BACTERIAL INFECTION; BLOOD CULTURE; CHILD CARE; CLINICAL TRIAL; COCHRANE LIBRARY; DEVELOPING COUNTRY; DRUG COST; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; EVIDENCE BASED MEDICINE; FEBRILE CONVULSION; FEVER; HUMAN; LIVER FAILURE; LIVER TOXICITY; MALARIA; MALNUTRITION; MEDLINE; PRESCRIPTION; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SEPSIS; TREATMENT OUTCOME; VIRUS INFECTION;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; CHILD; CLINICAL TRIALS; DRUG COSTS; FEVER; HUMANS; PRACTICE GUIDELINES; WORLD HEALTH;

EID: 0038015880     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Shann F. Paracetamol: use in children. Australian Prescriber 1995;18:33-4.
2. Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen. A practitioner-based randomized clinical trial. JAMI 1995;273:929-33.
3. Roberts NJ Jr. Impact of temperature elevation on immunological defenses. Reviews of infectious Diseases 1991;13:462-72.
4. Kluger MJ, Ringler DH, Anver MR. Fever and survival. Science 1975;188:166-8.
5. Bernheim HA, Kluger MJ. Effect of drug-induced antipyresis on survivai. Science 1976;193:237-9.
6. Carmichael LE, Barnes FD, Percy DH. Temperature as a factor in resistance of young puppies to canine herpesvirus. Journal of Infectious Diseases 1969;120:669-78.
7. Shann F. Antipyretics in severe sepsis. Lancet 1995;345:338.
8. Heub JE, Barbacci MB, Zimmerman HJ. Therapeutic misadventures with acetaminophen: hepatoxicity after multiple doses in children. Journal of Pediatrics 1998;132:22-7.
9. Kearns GL, Leeder JS, Wasserman GS. Acetaminophen overdose with therapeutic intent. Journal of Pediatrics 1998;132:5-8.
10. Rivera-Penera T, Gugig R, Davis J, McDiarmid S, Vargas J, Rosenthal P, et al. Outcome of acetaminophen overdose in pediatric patients and factors contributing to hepatotoxicity. Journal of Pediatrics 1997;130:300-4
11. Penna AC, Dawson KP, Penna CM. Is prescribing paracetamol 'pro re nata' acceptable? Journal of Paediatrics and Child Health 1993;29:104-6.
12. World Health Organization. Integrated Management of Childhood Illness, Geneva: World Health Organization; 2000. WHO document WHO/FCH/CAH/00.12.
13. Kramer MS, Naimark LE, Roberts-Brauer R, McDougall A, Leduc DG. Risks and benefits of paracetamol antipyresis in young children with fever of presumed viral origin. Lancet 1991;337:591-4.
14. Doran TF, De Angelis C, Baumgardner RA, Mellis ED. Acetaminophen: more harm than good for chickenpox? Journal of Pediatrics 1989;114:1045-8.
15. Hasday JD, Garrison A. Antipyretic therapy in patients with sepsis. Clinical Infectious Diseases 2000;31 Suppl 5:S234-41.
16. Munzenburger PJ, Robayo JR, del Valle J. Effect of antipyretics on the length of hospital stay of pediatric patients with bacterial infections. American Journal of Hospital Pharmacy 1981;33:861-3.
17. Kuikka A, Sivonen A, Emelianova A, Valtonen VV. Prognostic factors associated with improved outcomes of Eschericha coli bacteraemia in a Finnish university hospital. European Journal of Clinical Microbiology and Infectious Diseases 1997;16:125-34.
18. Kuikka A, Valtonen VV. Factors associated with improved outcome of Pseudomonas aeriginosa bacteraemia in a Finnish university hospital. European Journal of Clinical Microbiology and Infectious Diseases 1998;17:701-8.
19. Hoefs JC, Canawati HN, Sapico FL, Hopkins RR, Weiner J, Montogomerie JZ. Spontaneous bacterial peritonitis. Hepatology 1982;2:399-407.
20. Weinstein MP, Iannini PB, Stratton CW, Eickhoff TC. Spontaneous bacterial peritonitis. A review of 28 cases with emphasis on improved survival and factors influencing prognosis. American Journal of Medicine 1978;64:592-8.
21. Mackowiak PA, Demian SE, Sutker WL, Murphy FK, Smith JW, Tompsett R, et al. Infections of hairy cell leukemia. Clinical evidence of a pronounced defect in cell-mediated immunity. American Journal of Medicine 1980;68:718-24.
22. Shann F, Barker J, Poore P. Clinical signs that predict death in children with severe pneumonia. Pediatric Infectious Disease Journal 1989;8:852-5.
23. Bernard GR, Wheeler AP, Russell JA, Schein R, Summer WR, Steinberg KP, et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. New England Journal of Medicine 1997;336:912-8.
24. The Veterans Administration Systemic Sepsis Cooperative Study Group. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. New England Journal of Medicine 1987;317:659-65.
25. Clemmer TP, Fisher CJ Jr, Bone RC, Slotman GJ, Metz CA, Thomas FO. Hypothermia in the sepsis syndrome and clinical outcome. The Methylprednisolone Severe Sepsis Study Group. Critical Care Medicine 1992;20:1395-401.
26. DuPont HL, Spink WW. Infections due to Gram-negative organisms: an analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958-1966. Medicine (Baltimore) 1969;48:307-32.
27. Manthous CA, Hall JB, Olson D, Singh M, Chatila W, Pohlman A, et al. Effect of cooling on oxygen consumption in febrile critically ill patients. American Journal of Respiratory and Critical Care Medicine 1995;151:10-4.
28. Kwiatkowski D. Malaria toxins and the regulation of parasite density. Parasitology Today 1995;11:206-12.
29. Kwiatkowski D. Tumour necrosis factor, fever and fatality in falciparum malaria. Immunology Letters 1990;25:213-6.
30. Karunaweera ND, Grau GE, Gamage P, Carter R, Mendis KN. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proceedings of the National Academy of Sciences of the United States of America 1992;89:3200-3.
31. Taverne J, Tavernier J, Fiers W, Playfair JH. Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro. Clinical and Experimental Immunology 1987;67:1-4.
32. Kwiatkowski D. Febrile temperatures can synchronize the growth of Plasmodium falciparum in vitro. Journal of Experimental Medicine 1989;169:357-61.
33. Brandts CH, Ndjave M, Graninger W, Kremsner PG. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet 1997;350:704-9.
34. ter Kuile FO, Nosten F, Luxemburger C, Kyle D, Teja-Isavatharm P, Phaipun L, et al. Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients. Bulletin of the World Health Organization 1995;73:631-42.
35. Luxemburger C, van Vugt M, Slight T, Price RN, Chongsuphajaisiddhi T, Chanthavanich P, et al. Early vomiting of mefloquine in children with malaria is not modified by the timing of antipyretic treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene 1998;92:562-3.
36. Uhari M, Rantala H, Vainionpaa L, Kurttila R. Effect of acetaminophen and of low intermittent doses of diazepam on prevention of recurrences of febrile seizures. Journal of Pediatrics 1995;126:991-5.
37. Schnaiderman D, Lahat E, Sheefer T, Aladjem M. Antipyretic effectiveness of acetaminophen in febrile seizures: ongoing prophylaxis versus sporadic usage. European Journal of Pediatrics 1993;152:747-9.
38. Blake KV, Bailey D, Zietek GM, Hendeles L. Death of a child associated with multiple overdoses of acetaminophen and phenobarbitone. American Journal of Disease in Children 1978;132:466-73.
39. Heub JE, Bien JP. Acetaminophen use in children:! more is not better. Journal of Pediatrics 1997;130:175-7.
40. Wilson JT, Brown RD, Bocchini JA Jr Kearns GL. Efficacy, disposition and pharmacodynamics of aspirin, acetaminphen, and choline salicylate in young febrile children. Therapeutic Drug Monitoring 1982;4:147-80.
41. Penna A, Buchanan N. Paracetamol poisoning in children and hepatotoxicity. British Journal of Clinical Pharmacology 1991;32:143-9.
42. Management Services for Health (USA). International drug price indicator guide. Arlington: Management Services for Health (USA); 1999.
43. Meremikwu M, Oyo-Ita A. Paracetamol for treating fever in children. Cochrane Library 2003; 1:AB003676.
44. Mellouk S, Green SJ, Nacy CA, Hoffman SL. IFN-γ inhibits development of Plasmodium berghi exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism. Journal of Immunology 1991;146:3971-6.
45. Naotunne TS, Karunaweera ND, Del Giudice G, Kularatne MU, Grau GE, Carter R, et al. Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential. Journal Experimental Medicine 1991;173:523-9.
46. Curfs JHAJ, Van Der Meer JWM, Sauerwein RW, Eling WMC. Low dosages of interleukin-1 protect mice against lethal cerebral malaria. Journal of Experimental Medicine 1990;172:1287-91.
47. Woodman JP, Dimier IH, Bout DT. Human endothelia cells are activated by IFN-γ to inhibit Toxoplasmosis gondii replication: inhibition is due to a different mechanism from that existing in mouse macrophages and human fibroblasts. Journal of Immunology 1991;147:2019-23.
48. Liew FY, Li Y, Millotts S. Tumor necrosis factor-α synergizes with IFN-γ immediating killing of Leishmania major through the induction of nitric oxide. Journal of Immunology 1990;145:4306-10.
49. Torrico F, Heremans H, Rivera MT, Van Marck E, Billiau A, Carlier Y. Endogenous IFN-γ is required for resistance to acute Trypanosoma cruzi infection in mice. Journal of Immunology 1991;146:3626-32.
50. Ungar BVP, Kao T-C, Burris JA, Finkelman FD. Cryptosporidium infection in an adult mouse model: independent roles for IFN-γ and CD4+ T lymphocytes in protective immunity. Journal of Immunology 1991;147:1014-22.
51. Berheim HA, Bodel T, Askenase PW, Atkins E. Effects of fever on host defense mechanisms after infection of the lizard Diposaurus dorsalis. British Journal of Experimental Pathology 1978;59:76-84
52. Dinarello CA. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. Journal of Infectious Diseases 1991;163:1177-84.
53. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Annals of Internal Medicine 1993;119:771-8.